These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 19713051

  • 1. Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment.
    Elkader AK, Brands B, Callaghan R, Sproule BA.
    Drug Alcohol Depend; 2009 Dec 01; 105(3):209-14. PubMed ID: 19713051
    [Abstract] [Full Text] [Related]

  • 2. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients.
    Elkader AK, Brands B, Dunn E, Selby P, Sproule BA.
    J Clin Psychopharmacol; 2009 Feb 01; 29(1):77-81. PubMed ID: 19142113
    [Abstract] [Full Text] [Related]

  • 3. Patterns of symptom complaints in methadone maintenance patients.
    Dyer KR, White JM.
    Addiction; 1997 Nov 01; 92(11):1445-55. PubMed ID: 9519488
    [Abstract] [Full Text] [Related]

  • 4. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E, Schreiber S, Naumovsky Y, Adelson M.
    J Affect Disord; 2007 Apr 01; 99(1-3):213-20. PubMed ID: 17055063
    [Abstract] [Full Text] [Related]

  • 5. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC, Walsh SL, Bigelow GE, Eissenberg T, Stitzer ML.
    Psychopharmacology (Berl); 2002 May 01; 161(2):202-12. PubMed ID: 11981600
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
    Newcombe DA, Bochner F, White JM, Somogyi AA.
    Drug Alcohol Depend; 2004 Oct 05; 76(1):63-72. PubMed ID: 15380290
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Craving despite extremely high methadone dosage.
    de Vos JW, Ufkes JG, van Brussel GH, van den Brink W.
    Drug Alcohol Depend; 1996 Mar 05; 40(3):181-4. PubMed ID: 8861396
    [Abstract] [Full Text] [Related]

  • 9. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
    Dyer KR, Foster DJ, White JM, Somogyi AA, Menelaou A, Bochner F.
    Clin Pharmacol Ther; 1999 Jun 05; 65(6):685-94. PubMed ID: 10391674
    [Abstract] [Full Text] [Related]

  • 10. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S, Kemmler G, Ertl M, Riemer Y.
    Subst Use Misuse; 2006 Jun 05; 41(2):223-44. PubMed ID: 16393744
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stability of opioid craving over time as measured by visual analog scales.
    McMillan DE, Gilmore-Thomas K.
    Drug Alcohol Depend; 1996 Mar 05; 40(3):235-9. PubMed ID: 8861402
    [Abstract] [Full Text] [Related]

  • 13. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial.
    Soyka M, Lieb M, Kagerer S, Zingg C, Koller G, Lehnert P, Limmer C, Kuefner H, Hennig-Fast K.
    J Clin Psychopharmacol; 2008 Dec 05; 28(6):699-703. PubMed ID: 19011441
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Methadone-nicotine interactions in methadone maintenance treatment patients.
    Elkader AK, Brands B, Selby P, Sproule BA.
    J Clin Psychopharmacol; 2009 Jun 05; 29(3):231-8. PubMed ID: 19440076
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL.
    Addiction; 2005 Oct 05; 100(10):1496-509. PubMed ID: 16185211
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.